Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Safety Study of Edoxaban in Non-Valvular Atrial Fibrillation
NCT00504556Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of edoxaban in Atrial fibrillation (AFib), sponsored by Daiichi Sankyo Co., Ltd.. Started Jun 2007; status: completed.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00504556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00504556.